Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the Literature

Anders Kindberg Boysen(Aalborg University Hospital), Mette Nyegaard(Statens Serum Institut), Paw Jensen(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Preben Johansen(Chr. Hansen (Denmark))
Case Reports in Hematology
January 1, 2011
10.1155/2011/818469
Cited by 7

Related Papers

Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
|Blood|2009|390
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362